Application Sponsors
ANDA 211125 | TEVA PHARMS USA | |
Marketing Status
Application Products
001 | FOR SUSPENSION;ORAL | EQ 6MG BASE/ML | 0 | OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2019-02-27 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
TEVA PHARMS USA
cder:Array
(
[0] => Array
(
[ApplNo] => 211125
[companyName] => TEVA PHARMS USA
[docInserts] => ["",""]
[products] => [{"drugName":"OSELTAMIVIR PHOSPHATE","activeIngredients":"OSELTAMIVIR PHOSPHATE","strength":"EQ 6MG BASE\/ML","dosageForm":"FOR SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"02\/27\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-02-27
)
)